Similar articles

• Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture.

  Ahimastos AA, Natoli AK, Lawler A, Blombery PA, Kingwell BA. Ahimastos AA, et al. Hypertension. 2005 Jun;45(6):1194-9. doi: 10.1161/01.HYP.0000168945.44069.aa. Epub 2005 May 16. Hypertension. 2005. Retraction in: Hypertension. 2016 Jan;67(1):e1. doi: 10.1161/HYP.0000000000000038. PMID: 15897362 Retracted. Clinical Trial.
• Summaries for patients. Ramipril improves walking ability in patients with peripheral arterial disease.

  [No authors listed] [No authors listed] Ann Intern Med. 2006 May 2;144(9):I24. doi: 10.7326/0003-4819-144-9-200605020-00003. Ann Intern Med. 2006. Retraction in: Ann Intern Med. 2015 Dec 1;163(11):884. doi: 10.7326/M15-2647. PMID: 16670129 Retracted. No abstract available.
• Manipulation of the renin angiotensin system in peripheral arterial disease.

  Hobbs SD, Thomas ME, Bradbury AW. Hobbs SD, et al. Eur J Vasc Endovasc Surg. 2004 Dec;28(6):573-82. doi: 10.1016/j.ejvs.2004.08.003. Eur J Vasc Endovasc Surg. 2004. PMID: 15531190 Review.
• Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.

  Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, Yusuf S; HOPE study investigators. Ostergren J, et al. Eur Heart J. 2004 Jan;25(1):17-24. doi: 10.1016/j.ehj.2003.10.033. Eur Heart J. 2004. PMID: 14683738 Clinical Trial.
• [Possibilities of the use Angiotensin converting enzyme inhibitor in peripheral arterial disease].

  Zagidullin NSh, Valeeva KF, Zagidullin ShZ, Rezbaeva AG. Zagidullin NSh, et al. Kardiologiia. 2010;50(4):92-6. Kardiologiia. 2010. PMID: 20459427 Review. Russian. No abstract available.